For years, high sequencing costs prevented population-scale studies of rare variants for complex traits. However, with continued technological innovation, sequencing costs are decreasing, meaning ...
Whole-genome sequencing (WGS) is becoming increasingly common in clinical settings, with many laboratories already using it to identify the genetic causes of rare and undiagnosed genetic diseases ...